These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18540374)

  • 1. [Postprandial metabolic disorder].
    Mori Y
    Nihon Rinsho; 2008 Jun; 66(6):1219-29. PubMed ID: 18540374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
    Yamagishi S; Nakamura K; Takeuchi M
    Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Fluid Milk in Attenuating Postprandial Hyperglycemia and Hypertriglyceridemia.
    Leary M; Tanaka H
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33322540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of oxidative stress and metabolic homeostasis by the suppression of postprandial hyperglycemia.
    Takeda E; Arai H; Yamamoto H; Okumura H; Taketani Y
    J Med Invest; 2005 Nov; 52 Suppl():259-65. PubMed ID: 16366512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherogenicity of postprandial hyperglycemia and lipotoxicity.
    Ceriello A; Genovese S
    Rev Endocr Metab Disord; 2016 Mar; 17(1):111-6. PubMed ID: 26880302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The postprandial state and risk of cardiovascular disease.
    Lefèbvre PJ; Scheen AJ
    Diabet Med; 1998; 15 Suppl 4():S63-8. PubMed ID: 9868996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues.
    Firth RG; Bell PM; Marsh HM; Hansen I; Rizza RA
    J Clin Invest; 1986 May; 77(5):1525-32. PubMed ID: 3517067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.
    Lewis GF; Carpentier A; Adeli K; Giacca A
    Endocr Rev; 2002 Apr; 23(2):201-29. PubMed ID: 11943743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postprandial dysmetabolism: the missing link between diabetes and cardiovascular events?
    Bell DS; O'Keefe JH; Jellinger P
    Endocr Pract; 2008; 14(1):112-24. PubMed ID: 18238751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial lipemia: an under-recognized atherogenic factor in patients with diabetes mellitus.
    Pastromas S; Terzi AB; Tousoulis D; Koulouris S
    Int J Cardiol; 2008 May; 126(1):3-12. PubMed ID: 17689745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of blood glucose levels in the pathogenesis of (atherosclerotic) macroangiopathy].
    Simon K
    Orv Hetil; 2004 Apr; 145(16):861-6. PubMed ID: 15156691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
    Sjöholm A
    Lakartidningen; 2001 Feb; 98(9):937-40. PubMed ID: 11292972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A whole-grain cereal-based diet lowers postprandial plasma insulin and triglyceride levels in individuals with metabolic syndrome.
    Giacco R; Costabile G; Della Pepa G; Anniballi G; Griffo E; Mangione A; Cipriano P; Viscovo D; Clemente G; Landberg R; Pacini G; Rivellese AA; Riccardi G
    Nutr Metab Cardiovasc Dis; 2014 Aug; 24(8):837-44. PubMed ID: 24598599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxytyrosol prevents diet-induced metabolic syndrome and attenuates mitochondrial abnormalities in obese mice.
    Cao K; Xu J; Zou X; Li Y; Chen C; Zheng A; Li H; Li H; Szeto IM; Shi Y; Long J; Liu J; Feng Z
    Free Radic Biol Med; 2014 Feb; 67():396-407. PubMed ID: 24316371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of hyperglycemia and insulin with diabetic cardiovascular complications.
    Khamaisi M; Wainstein J; Hancu N; Milicevic Z; Raz I
    Isr Med Assoc J; 2003 Feb; 5(2):116-9. PubMed ID: 12674662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetes.
    Vakkilainen J; Mero N; Schweizer A; Foley JE; Taskinen MR
    Diabetes Metab Res Rev; 2002; 18(6):484-90. PubMed ID: 12469362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial dysmetabolism and the heart.
    Garber AJ
    Heart Fail Clin; 2012 Oct; 8(4):563-73. PubMed ID: 22999240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Greater impairment of postprandial triacylglycerol than glucose response in metabolic syndrome subjects with fasting hyperglycaemia.
    Jackson KG; Walden CM; Murray P; Smith AM; Minihane AM; Lovegrove JA; Williams CM
    Metabolism; 2013 Aug; 62(8):1065-9. PubMed ID: 23598085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.